Cargando…

Challenges and Opportunities in Developing Respiratory Syncytial Virus Therapeutics

Two meetings, one sponsored by the Wellcome Trust in 2012 and the other by the Global Virology Foundation in 2013, assembled academic, public health and pharmaceutical industry experts to assess the challenges and opportunities for developing antivirals for the treatment of respiratory syncytial vir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simões, Eric A. F., DeVincenzo, John P., Boeckh, Michael, Bont, Louis, Crowe, James E., Griffiths, Paul, Hayden, Frederick G., Hodinka, Richard L., Smyth, Rosalind L., Spencer, Keith, Thirstrup, Steffen, Walsh, Edward E., Whitley, Richard J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2015
Materias:	Supplement Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345819/ https://www.ncbi.nlm.nih.gov/pubmed/25713060 http://dx.doi.org/10.1093/infdis/jiu828

Ejemplares similares

Immunoprophylaxis of respiratory syncytial virus: global experience
por: Simoes, Eric AF
Publicado: (2002)

Asthma: a major pediatric health issue
por: Smyth, Rosalind L
Publicado: (2002)

Global Respiratory Syncytial Virus–Related Infant Community Deaths
por: Mazur, Natalie I, et al.
Publicado: (2021)

The Burden of Respiratory Syncytial Virus Lower Respiratory Tract Disease in Infants in the United States: A Synthesis
por: Simões, Eric A F
Publicado: (2022)

World Health Organization Influenza-Like Illness Underestimates the Burden of Respiratory Syncytial Virus Infection in Community-Dwelling Older Adults
por: Korsten, Koos, et al.
Publicado: (2021)

An epidemiological study of respiratory syncytial virus associated hospitalizations in Denmark
por: Stensballe, Lone Graff
Publicado: (2002)

Prevention and treatment of respiratory syncytial virus bronchiolitis and postbronchiolitic wheezing
por: Kimpen, Jan LL
Publicado: (2002)

Respiratory syncytial virus (RSV) and its propensity for causing bronchiolitis
por: Pickles, Raymond J, et al.
Publicado: (2015)

Pathophysiological mechanisms for the respiratory syncytial virus-reactive airway disease link
por: Piedimonte, Giovanni
Publicado: (2002)

Potential therapeutic implications of new insights into respiratory syncytial virus disease
por: Openshaw, Peter JM
Publicado: (2002)

Clinical perspectives on the association between respiratory syncytial virus and reactive airway disease
por: Sigurs, Nele
Publicado: (2002)

Performance Assessment of a Rapid Molecular Respiratory Syncytial Virus Point-of-Care Test: A Prospective Community Study in Older Adults
por: Zuurbier, Roy P, et al.
Publicado: (2022)

Rationale for full-season dosing for passive antibody prophylaxis of respiratory syncytial virus
por: Makari, Doris, et al.
Publicado: (2014)

Introduction. RSV and RAD: possibilities for prevention? The link between respiratory syncytial virus and reactive airway disease
por: Carbonell-Estrany, Xavier, et al.
Publicado: (2002)

The Burden of Respiratory Syncytial Virus in Children Under 2 Years of Age in a Rural Community in Maharashtra, India
por: Satav, Ashish, et al.
Publicado: (2021)

Mortality From Respiratory Syncytial Virus in Children Under 2 Years of Age: A Prospective Community Cohort Study in Rural Maharashtra, India
por: Simões, Eric A F, et al.
Publicado: (2021)

Cost of Respiratory Syncytial Virus Infections in US Infants: Systematic Literature Review and Analysis
por: Bowser, Diana M, et al.
Publicado: (2022)

Second generation HIV surveillance in Pakistan: policy challenges and opportunities
por: Munro, Michelle, et al.
Publicado: (2013)

Biosimilars: Opportunities to Promote Optimization Through Payer and Provider Collaboration
por: Manolis, Chronis H., et al.
Publicado: (2016)

Viral Specific Factors Contribute to Clinical Respiratory Syncytial Virus Disease Severity Differences in Infants
por: Thompson, Tonya M, et al.
Publicado: (2015)

Risk Factors for Respiratory Syncytial Virus–Associated Community Deaths in Zambian Infants
por: Murphy, Caitriona, et al.
Publicado: (2021)

WHAT CLINICIANS NEED TO KNOW ABOUT ANTIVIRAL DRUGS AND VIRAL RESISTANCE
por: Hodinka, Richard L.
Publicado: (1997)

Association of C-Reactive Protein With Bacterial and Respiratory Syncytial Virus–Associated Pneumonia Among Children Aged <5 Years in the PERCH Study
por: Higdon, Melissa M., et al.
Publicado: (2017)

Inequality of opportunities in health and death: an investigation from birth to middle age in Great Britain
por: Bricard, Damien, et al.
Publicado: (2020)

The Great Opportunity: Cultivating Scientific Inquiry in Medical Residency
por: Vyas, Jatin M, et al.
Publicado: (2018)

Uncovering critical properties of the human respiratory syncytial virus by combining in vitro assays and in silico analyses
por: Beauchemin, Catherine A. A., et al.
Publicado: (2019)

Community Mortality Due to Respiratory Syncytial Virus in Argentina: Population-based Surveillance Study
por: Caballero, Mauricio T, et al.
Publicado: (2021)

National quality improvement policies and strategies in European healthcare systems
por: Spencer, E, et al.
Publicado: (2009)

Evaluation of recent New Vaccine Surveillance Network data regarding respiratory syncytial virus hospitalization rates in US preterm infants
por: DeVincenzo, John P., et al.
Publicado: (2016)

Partner notification for sexually transmitted infections in the modern world: a practitioner perspective on challenges and opportunities
por: Bell, Gill, et al.
Publicado: (2011)

Impact of Respiratory Syncytial Virus on Child, Caregiver, and Family Quality of Life in the United States: Systematic Literature Review and Analysis( )
por: Glaser, Elizabeth L, et al.
Publicado: (2022)

Human Metapneumovirus in Severe Respiratory Syncytial Virus Bronchiolitis
por: Greensill, Julie, et al.
Publicado: (2003)

The Use of Death Certificate Data to Characterize Mortality Associated With Respiratory Syncytial Virus, Unspecified Bronchiolitis, and Influenza in the United States, 1999–2018
por: Hansen, Chelsea L, et al.
Publicado: (2022)

Altered gut microbiota in infants is associated with respiratory syncytial virus disease severity
por: Harding, Jeffrey N., et al.
Publicado: (2020)

Relating plaque morphology to respiratory syncytial virus subgroup, viral load, and disease severity in children
por: Kim, Young-In, et al.
Publicado: (2015)

Magnetic resonance imaging: opportunities for rheumatoid arthritis disease assessment and monitoring long-term treatment outcomes
por: Emery, Paul
Publicado: (2002)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
por: Floto, R Andres, et al.
Publicado: (2016)

923. EDP-938, A Respiratory Syncytial Virus (RSV) antiviral, demonstrates a high barrier to resistance in a human challenge study
por: Levene, Rachel E, et al.
Publicado: (2023)

Science-based policy: targeted nutrition for all ages and the role of bioactives
por: Kalache, Alexandre, et al.
Publicado: (2021)

Deaths Attributed to Respiratory Syncytial Virus in Young Children in High–Mortality Rate Settings: Report from Child Health and Mortality Prevention Surveillance (CHAMPS)
por: Blau, Dianna M, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1a7vat1lm894bai26m3q1v8mhe